                               SEQUENCE LISTING                               

<110> AGILENT TECHNOLOGIES, INC.

<120> ANALYTE DETECTION VIA BINDING MOLECULE-ASSOCIATED 
      ENZYME ASSAY

<130> 10070697-02-WO

<140>
<141>

<150> 11/897,886
<151> 2007-08-31

<160> 19                            

<170> PatentIn Ver. 3.3

<210> 1
<211> 5
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 1
ccctt                                                             5     


<210> 2
<211> 53
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 2
tgacgcccga agccaagtgc gggacggctt ctccagcttg gccccttatg ggt        53    


<210> 3
<211> 23
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 3
tcgttcccat aaggggccaa ttc                                         23    


<210> 4
<211> 39
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 4
atgggaacga gcagaccgac cgctagacag ctccgtgga                        39    


<210> 5
<211> 29
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 5
tccacggagc tgtctagcgg tcggtctgc                                   29    


<210> 6
<211> 47
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 6
tgacgcccga agccaagtgc gggacggctt ctccagcttg gcccctt               47    


<210> 7
<211> 86
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 7
tgacgcccga agccaagtgc gggacggctt ctccagcttg gccccttatg ggaacgagca 60    
gaccgaccgc tagacagctc cgtgga                                      86    


<210> 8
<211> 52
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 8
tccacggagc tgtctagcgg tcggtctgct cgttcccata aggggccaat tc         52    


<210> 9
<211> 190
<212> RNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 9
gaauuggagc uccaccgcgg uggcggccgc ucuagaacua guggaucccc cgggcugcag 60    
gaauucgaua ucaagcuuau cgauaccguc gaccucgagg gggggcccgg uacccagcuu 120   
uuguucccuu uagugagggu uaauugcgcg cuuggcguaa ucauggucau agcuguuucc 180   
ugugugaaau                                                        190   


<210> 10
<211> 19
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 10
tccacggagc tgtctagcg                                              19    


<210> 11
<211> 19
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 11
gtgaaccgaa gcccgcagt                                              19    


<210> 12
<211> 6
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 12
atgggt                                                            6     


<210> 13
<211> 11
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<220>
<221> modified_base
<222> (6)..(11)
<223> a, c, g, t, unknown or other

<400> 13
cccttnnnnn n                                                      11    


<210> 14
<211> 53
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 14
acccataagg ggccaagctg gagaagccgt cccgcacttg gcttcgggcg tca        53    


<210> 15
<211> 38
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 15
tgggtacgag cagaccgacc gctagacagc tccgtgga                         38    


<210> 16
<211> 33
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 16
tccacggagc tgtctagcgg tcggtctgct cgt                              33    


<210> 17
<211> 275
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 17
Met Gly Ser Ser His His His His His His Ala Ala Glu Ala Gly Ile  
  1               5                  10                  15    

Thr Gly Thr Trp Tyr Asn Gln Leu Gly Ser Thr Phe Ile Val Thr Ala  
             20                  25                  30        

Gly Ala Asp Gly Ala Leu Thr Gly Thr Tyr Glu Ser Ala Val Gly Asn  
         35                  40                  45            

Ala Glu Ser Arg Tyr Val Leu Thr Gly Arg Tyr Asp Ser Ala Pro Ala  
     50                  55                  60                

Thr Asp Gly Ser Gly Thr Ala Leu Gly Trp Thr Val Ala Trp Lys Asn  
 65                  70                  75                  80

Asn Tyr Arg Asn Ala His Ser Ala Thr Thr Trp Ser Gly Gln Tyr Val  
                 85                  90                  95    

Gly Gly Ala Glu Ala Arg Ile Asn Thr Gln Trp Leu Leu Thr Ser Gly  
            100                 105                 110        

Thr Thr Glu Ala Asn Val Trp Lys Ser Thr Leu Val Gly His Asp Thr  
        115                 120                 125            

Phe Thr Lys Val Lys Pro Ser Ala Ala Ser Ile Asp Ala Ala Lys Lys  
    130                 135                 140                

Ala Gly Val Asn Asn Gly Asn Pro Leu Asp Ala Val Gln Gln Leu Glu  
145                 150                 155                 160

Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly  
                165                 170                 175    

Gly Gly Ile Arg Ile Lys Asp Leu Arg Thr Tyr Gly Val Asn Tyr Thr  
            180                 185                 190        

Phe Leu Tyr Asn Phe Trp Thr Asn Val Lys Ser Ile Ser Pro Leu Pro  
        195                 200                 205            

Ser Pro Lys Lys Leu Ile Ala Leu Thr Ile Lys Gln Thr Ala Glu Val  
    210                 215                 220                

Val Gly His Thr Pro Ser Ile Ser Lys Arg Ala Tyr Met Ala Thr Thr  
225                 230                 235                 240

Ile Leu Glu Met Val Lys Asp Lys Asn Phe Leu Asp Val Val Ser Lys  
                245                 250                 255    

Thr Thr Phe Asp Glu Phe Leu Ser Ile Val Val Asp His Val Lys Ser  
            260                 265                 270        

Ser Thr Asp                                                      
        275


<210> 18
<211> 400
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 18
Met Arg Ala Leu Phe Tyr Lys Asp Gly Lys Leu Phe Thr Asp Asn Asn  
  1               5                  10                  15    

Phe Leu Asn Pro Val Ser Asp Asp Asn Pro Ala Tyr Glu Val Leu Gln  
             20                  25                  30        

His Val Lys Ile Pro Thr His Leu Thr Asp Val Val Val Tyr Glu Gln  
         35                  40                  45            

Thr Trp Glu Glu Ala Leu Thr Arg Leu Ile Phe Val Gly Ser Asp Ser  
     50                  55                  60                

Lys Gly Arg Arg Gln Tyr Phe Tyr Gly Lys Met His Val Gln Asn Arg  
 65                  70                  75                  80

Asn Ala Lys Arg Asp Arg Ile Phe Val Arg Val Tyr Asn Val Met Lys  
                 85                  90                  95    

Arg Ile Asn Cys Phe Ile Asn Lys Asn Ile Lys Lys Ser Ser Thr Asp  
            100                 105                 110        

Ser Asn Tyr Gln Leu Ala Val Phe Met Leu Met Glu Thr Met Phe Phe  
        115                 120                 125            

Ile Arg Phe Gly Lys Met Lys Tyr Leu Lys Glu Asn Glu Thr Val Gly  
    130                 135                 140                

Leu Leu Thr Leu Lys Asn Lys His Ile Glu Ile Ser Pro Asp Glu Ile  
145                 150                 155                 160

Val Ile Lys Phe Val Gly Lys Asp Lys Val Ser His Glu Phe Val Val  
                165                 170                 175    

His Lys Ser Asn Arg Leu Tyr Lys Pro Leu Leu Lys Leu Thr Asp Asp  
            180                 185                 190        

Ser Ser Pro Glu Glu Phe Leu Phe Asn Lys Leu Ser Glu Arg Lys Val  
        195                 200                 205            

Tyr Glu Cys Ile Lys Gln Phe Gly Gly Gly Gly Gly Ser Gly Gly Gly  
    210                 215                 220                

Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly  
225                 230                 235                 240

Arg Arg Ile Leu Val Ser Ala Ala Glu Ala Gly Ile Thr Gly Thr Trp  
                245                 250                 255    

Tyr Asn Gln Leu Gly Ser Thr Phe Ile Val Thr Ala Gly Ala Asp Gly  
            260                 265                 270        

Ala Leu Thr Gly Thr Tyr Glu Ser Ala Val Gly Asn Ala Glu Ser Arg  
        275                 280                 285            

Tyr Val Leu Thr Gly Arg Tyr Asp Ser Ala Pro Ala Thr Asp Gly Ser  
    290                 295                 300                

Gly Thr Ala Leu Gly Trp Thr Val Ala Trp Lys Asn Asn Tyr Arg Asn  
305                 310                 315                 320

Ala His Ser Ala Thr Thr Trp Ser Gly Gln Tyr Val Gly Gly Ala Glu  
                325                 330                 335    

Ala Arg Ile Asn Thr Gln Trp Leu Leu Thr Ser Gly Thr Thr Glu Ala  
            340                 345                 350        

Asn Val Trp Lys Ser Thr Leu Val Gly His Asp Thr Phe Thr Lys Val  
        355                 360                 365            

Lys Pro Ser Ala Ala Ser Ile Asp Ala Ala Lys Lys Ala Gly Val Asn  
    370                 375                 380                

Asn Gly Asn Pro Leu Asp Ala Val Gln Gln His His His His His His  
385                 390                 395                 400
                                                              

<210> 19
<211> 314
<212> PRT
<213> Vaccinia virus

<400> 19
Met Arg Ala Leu Phe Tyr Lys Asp Gly Lys Leu Phe Thr Asp Asn Asn  
  1               5                  10                  15    

Phe Leu Asn Pro Val Ser Asp Asp Asn Pro Ala Tyr Glu Val Leu Gln  
             20                  25                  30        

His Val Lys Ile Pro Thr His Leu Thr Asp Val Val Val Tyr Glu Gln  
         35                  40                  45            

Thr Trp Glu Glu Ala Leu Thr Arg Leu Ile Phe Val Gly Ser Asp Ser  
     50                  55                  60                

Lys Gly Arg Arg Gln Tyr Phe Tyr Gly Lys Met His Val Gln Asn Arg  
 65                  70                  75                  80

Asn Ala Lys Arg Asp Arg Ile Phe Val Arg Val Tyr Asn Val Met Lys  
                 85                  90                  95    

Arg Ile Asn Cys Phe Ile Asn Lys Asn Ile Lys Lys Ser Ser Thr Asp  
            100                 105                 110        

Ser Asn Tyr Gln Leu Ala Val Phe Met Leu Met Glu Thr Met Phe Phe  
        115                 120                 125            

Ile Arg Phe Gly Lys Met Lys Tyr Leu Lys Glu Asn Glu Thr Val Gly  
    130                 135                 140                

Leu Leu Thr Leu Lys Asn Lys His Ile Glu Ile Ser Pro Asp Glu Ile  
145                 150                 155                 160

Val Ile Lys Phe Val Gly Lys Asp Lys Val Ser His Glu Phe Val Val  
                165                 170                 175    

His Lys Ser Asn Arg Leu Tyr Lys Pro Leu Leu Lys Leu Thr Asp Asp  
            180                 185                 190        

Ser Ser Pro Glu Glu Phe Leu Phe Asn Lys Leu Ser Glu Arg Lys Val  
        195                 200                 205            

Tyr Glu Cys Ile Lys Gln Phe Gly Ile Arg Ile Lys Asp Leu Arg Thr  
    210                 215                 220                

Tyr Gly Val Asn Tyr Thr Phe Leu Tyr Asn Phe Trp Thr Asn Val Lys  
225                 230                 235                 240

Ser Ile Ser Pro Leu Pro Ser Pro Lys Lys Leu Ile Ala Leu Thr Ile  
                245                 250                 255    

Lys Gln Thr Ala Glu Val Val Gly His Thr Pro Ser Ile Ser Lys Arg  
            260                 265                 270        

Ala Tyr Met Ala Thr Thr Ile Leu Glu Met Val Lys Asp Lys Asn Phe  
        275                 280                 285            

Leu Asp Val Val Ser Lys Thr Thr Phe Asp Glu Phe Leu Ser Ile Val  
    290                 295                 300                

Val Asp His Val Lys Ser Ser Thr Asp Gly                          
305                 310                

